Search results
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 6 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced Monday that in phase 3 clinical trials ...
Indonesia ramps up fight against tuberculosis amid concerns on economic impact - BusinessWorld...
BusinessWorld· 6 days agoIndonesia plans to run clinical trials of several vaccines to fight surging cases of tuberculosis (TB) this year, with concerns the disease might affect economic growth, ministers said on Monday ...
Moderna's combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Morningstar· 6 days agoModerna Inc.'s (MRNA) experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical trial data the company ...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 3 days agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines have been successfully used for several decades in Australia and around the world.
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 6 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, in an advanced clinical trial that included adults ages 50 ...